Flag­ship re­fo­cus­es stealth RNA biotech; Mesoblast en­acts pay cuts for ex­ec­u­tives

Ra­di­al Ther­a­peu­tics, a stealth-stage start­up in­side the biotech in­cu­ba­tor Flag­ship Pi­o­neer­ing, is re­fo­cus­ing.

“Un­for­tu­nate­ly, we found out re­cent­ly that Ra­di­al has de­cid­ed to stop pur­su­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER